Literature DB >> 21597675

Clinical analysis of skin lesions in 796 Chinese HIV- positive patients.

Xiao-jie Huang1, Hai-ying Li, De-xi Chen, Xi-cheng Wang, Zai-chun Li, Ya-song Wu, Tong Zhang, Yan-qing Gao, Hao Wu.   

Abstract

Skin lesions are often associated with human immunodeficiency virus (HIV) infection, reflecting the immunocompromised status of the individual. We investigated the relationship between skin lesions and immune function in a retrospective study of 796 Chinese HIV patients with and without highly active antiretroviral therapy (HAART). Of the 651 patients who had not received HAART, we found that 531 (81.6%) had apparent skin lesions. The incidence of infectious skin diseases (fungi, viruses, bacteria, spirochetes and parasites) and non-infectious skin diseases (excluding skin cancer) was 68.8% and 34.9%, respectively. Mean CD4(+) T-cell counts and CD4(+)/CD8(+) ratios were lower in patients with skin lesions than in patients without lesions (178 ± 96/µl vs. 306 ± 189/µl (p < 0.05) and 0.22 vs. 0.34 (p < 0.01), respectively). Candidiasis (25.8%), eczema (19.2%), nodular prurigo (13.8%), dermatophyte infections (10.6%) and herpes zoster (9.4%) were most common in Chinese patients with HIV. Among the 145 patients who had started HAART, there was a significantly lower prevalence of skin diseases (29.0%), although drug eruptions (12.4%) were more commonly observed. These findings indicate that HAART often reduces the incidence of infectious and non-infectious skin lesions in patients with HIV, but can itself be the cause of drug eruptions.

Entities:  

Mesh:

Year:  2011        PMID: 21597675     DOI: 10.2340/00015555-1107

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients.

Authors:  Jennifer Tan; Ana Pina; João Borges-Costa
Journal:  J Int Assoc Provid AIDS Care       Date:  2018 Jan-Dec

2.  Effect of antiretroviral therapy on mucocutaneous manifestations among Human Immunodeficiency Virus-infected patients in a tertiary care centre in South India.

Authors:  Nagendran Prabhakaran; Telanseri J Jaisankar; Abdoul Hamide; Munisamy Malathi; Rashmi Kumari; Devinder Mohan Thappa
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jul-Dec

3.  Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China.

Authors:  Yu-Ye Li; Yong-Mei Jin; Li-Ping He; Jin-Song Bai; Jun Liu; Min Yu; Jian-Hua Chen; Jing Wen; Yi-Qun Kuang
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

Review 4.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

5.  Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis.

Authors:  Yuanyuan Qin; Xiaojie Huang; Hui Chen; Xinchao Liu; Yao Li; Jianhua Hou; Aixin Li; Xiaofeng Yan; Yaokai Chen
Journal:  BMC Infect Dis       Date:  2020-07-29       Impact factor: 3.090

6.  Allergic diseases in subjects under 18 years living with HIV.

Authors:  Leandro S Linhar; Jefferson Traebert; Dayani Galato; Rosemeri M da Silva; Fabiana Schuelter-Trevisol; Natália S Rovaris; Jane da Silva
Journal:  Allergy Asthma Clin Immunol       Date:  2014-07-07       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.